chlordiazepoxide has been researched along with Labhart-Willi Syndrome in 1 studies
Chlordiazepoxide: An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal.
chlordiazepoxide : A benzodiazepine that is 3H-1,4-benzodiazepine 4-oxide substituted by a chloro group at position 7, a phenyl group at position 5 and a methylamino group at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fieldstone, A | 1 |
| Zipf, WB | 1 |
| Sarter, MF | 1 |
| Berntson, GG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Understanding the Role of Gut Microbiota in Hyperphagia in Prader-Willi Syndrome[NCT05541003] | Phase 2 | 12 participants (Actual) | Interventional | 2023-01-06 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for chlordiazepoxide and Labhart-Willi Syndrome
| Article | Year |
|---|---|
Food intake in Prader-Willi syndrome and controls with obesity after administration of a benzodiazepine receptor agonist.
Topics: Adolescent; Adult; Child; Chlordiazepoxide; Eating; Female; GABA-A Receptor Agonists; Humans; Male; | 1998 |